Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Letairis Market Report 2016

  • QYR766554
  • 112 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Letairis

Revenue, means the sales value of Letairis

This report studies sales (consumption) of Letairis in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Pfizer, Inc. (US)

GlaxoSmithKline Plc (UK)

Bayer HealthCare Pharmaceuticals (Germany)

Sanofi S.A (France)

Daiichi Sankyo Co., Ltd. (Japan)

Eli Lilly and Company (US)

The Novartis Group (Switzerland)

Actelion Pharmaceuticals Ltd. (Switzerland)

Nippon Shinyaku Co., Ltd. (Japan)

Cipla Limited (India)

Arena Pharmaceuticals, Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Letairis in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on sales, market share and growth rate of Letairis in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Europe Letairis Market Report 2016

1 Letairis Overview

1.1 Product Overview and Scope of Letairis

1.2 Classification of Letairis

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Letairis

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Letairis Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Letairis (2011-2021)

1.5.1 Europe Letairis Sales and Growth Rate (2011-2021)

1.5.2 Europe Letairis Revenue and Growth Rate (2011-2021)

2 Europe Letairis by Manufacturers, Type and Application

2.1 Europe Letairis Market Competition by Manufacturers

2.1.1 Europe Letairis Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Letairis Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Letairis (Volume and Value) by Type

2.2.1 Europe Letairis Sales and Market Share by Type (2011-2016)

2.2.2 Europe Letairis Revenue and Market Share by Type (2011-2016)

2.3 Europe Letairis (Volume and Value) by Countries

2.3.1 Europe Letairis Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Letairis Revenue and Market Share by Countries (2011-2016)

2.4 Europe Letairis (Volume) by Application

3 Germany Letairis (Volume, Value and Sales Price)

3.1 Germany Letairis Sales and Value (2011-2016)

3.1.1 Germany Letairis Sales and Growth Rate (2011-2016)

3.1.2 Germany Letairis Revenue and Growth Rate (2011-2016)

3.1.3 Germany Letairis Sales Price Trend (2011-2016)

3.2 Germany Letairis Sales and Market Share by Manufacturers

3.3 Germany Letairis Sales and Market Share by Type

3.4 Germany Letairis Sales and Market Share by Application

4 France Letairis (Volume, Value and Sales Price)

4.1 France Letairis Sales and Value (2011-2016)

4.1.1 France Letairis Sales and Growth Rate (2011-2016)

4.1.2 France Letairis Revenue and Growth Rate (2011-2016)

4.1.4 France Letairis Sales Price Trend (2011-2016)

4.2 France Letairis Sales and Market Share by Manufacturers

4.3 France Letairis Sales and Market Share by Type

4.4 France Letairis Sales and Market Share by Application

5 UK Letairis (Volume, Value and Sales Price)

5.1 UK Letairis Sales and Value (2011-2016)

5.1.1 UK Letairis Sales and Growth Rate (2011-2016)

5.1.2 UK Letairis Revenue and Growth Rate (2011-2016)

5.1.5 UK Letairis Sales Price Trend (2011-2016)

5.2 UK Letairis Sales and Market Share by Manufacturers

5.3 UK Letairis Sales and Market Share by Type

5.4 UK Letairis Sales and Market Share by Application

6 Russia Letairis (Volume, Value and Sales Price)

6.1 Russia Letairis Sales and Value (2011-2016)

6.1.1 Russia Letairis Sales and Growth Rate (2011-2016)

6.1.2 Russia Letairis Revenue and Growth Rate (2011-2016)

6.1.6 Russia Letairis Sales Price Trend (2011-2016)

6.2 Russia Letairis Sales and Market Share by Manufacturers

6.3 Russia Letairis Sales and Market Share by Type

6.4 Russia Letairis Sales and Market Share by Application

7 Italy Letairis (Volume, Value and Sales Price)

7.1 Italy Letairis Sales and Value (2011-2016)

7.1.1 Italy Letairis Sales and Growth Rate (2011-2016)

7.1.2 Italy Letairis Revenue and Growth Rate (2011-2016)

7.1.7 Italy Letairis Sales Price Trend (2011-2016)

7.2 Italy Letairis Sales and Market Share by Manufacturers

7.3 Italy Letairis Sales and Market Share by Type

7.4 Italy Letairis Sales and Market Share by Application

8 Spain Letairis (Volume, Value and Sales Price)

8.1 Spain Letairis Sales and Value (2011-2016)

8.1.1 Spain Letairis Sales and Growth Rate (2011-2016)

8.1.2 Spain Letairis Revenue and Growth Rate (2011-2016)

8.1.8 Spain Letairis Sales Price Trend (2011-2016)

8.2 Spain Letairis Sales and Market Share by Manufacturers

8.3 Spain Letairis Sales and Market Share by Type

8.4 Spain Letairis Sales and Market Share by Application

9 Benelux Letairis (Volume, Value and Sales Price)

9.1 Benelux Letairis Sales and Value (2011-2016)

9.1.1 Benelux Letairis Sales and Growth Rate (2011-2016)

9.1.2 Benelux Letairis Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Letairis Sales Price Trend (2011-2016)

9.2 Benelux Letairis Sales and Market Share by Manufacturers

9.3 Benelux Letairis Sales and Market Share by Type

9.4 Benelux Letairis Sales and Market Share by Application

10 Europe Letairis Manufacturers Analysis

10.1 Pfizer, Inc. (US)

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Letairis Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Pfizer, Inc. (US) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 GlaxoSmithKline Plc (UK)

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Letairis Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 GlaxoSmithKline Plc (UK) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Bayer HealthCare Pharmaceuticals (Germany)

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Letairis Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Bayer HealthCare Pharmaceuticals (Germany) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Sanofi S.A (France)

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Letairis Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Sanofi S.A (France) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Daiichi Sankyo Co., Ltd. (Japan)

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Letairis Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Daiichi Sankyo Co., Ltd. (Japan) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Eli Lilly and Company (US)

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Letairis Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Eli Lilly and Company (US) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 The Novartis Group (Switzerland)

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Letairis Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 The Novartis Group (Switzerland) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Actelion Pharmaceuticals Ltd. (Switzerland)

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Letairis Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Actelion Pharmaceuticals Ltd. (Switzerland) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Nippon Shinyaku Co., Ltd. (Japan)

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Letairis Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Nippon Shinyaku Co., Ltd. (Japan) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Cipla Limited (India)

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Letairis Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Cipla Limited (India) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Arena Pharmaceuticals, Inc. (US)

11 Letairis Manufacturing Cost Analysis

11.1 Letairis Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Letairis

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Letairis Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Letairis Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Letairis Market Forecast (2016-2021)

14.1 Germany Letairis Sales Forecast (2016-2021)

14.2 France Letairis Sales Forecast (2016-2021)

14.3 UK Letairis Sales Forecast (2016-2021)

14.4 Russia Letairis Sales Forecast (2016-2021)

14.5 Italy Letairis Sales Forecast (2016-2021)

14.6 Spain Letairis Sales Forecast (2016-2021)

14.7 Benelux Letairis Sales Forecast (2016-2021)

14.8 Europe Letairis Sales Forecast by Type (2016-2021)

14.9 Europe Letairis Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Letairis

Table Classification of Letairis

Figure Europe Sales Market Share of Letairis by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Letairis

Figure Europe Sales Market Share of Letairis by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Letairis Revenue and Growth Rate (2011-2021)

Figure France Letairis Revenue and Growth Rate (2011-2021)

Figure UK Letairis Revenue and Growth Rate (2011-2021)

Figure Russia Letairis Revenue and Growth Rate (2011-2021)

Figure Italy Letairis Revenue and Growth Rate (2011-2021)

Figure Spain Letairis Revenue and Growth Rate (2011-2021)

Figure Benelux Letairis Revenue and Growth Rate (2011-2021)

Figure Europe Letairis Sales and Growth Rate (2011-2021)

Figure Europe Letairis Revenue and Growth Rate (2011-2021)

Table Europe Letairis Sales of Key Manufacturers (2015 and 2016)

Table Europe Letairis Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Letairis Sales Share by Manufacturers

Figure 2016 Letairis Sales Share by Manufacturers

Table Europe Letairis Revenue by Manufacturers (2015 and 2016)

Table Europe Letairis Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Letairis Revenue Share by Manufacturers

Table 2016 Europe Letairis Revenue Share by Manufacturers

Table Europe Letairis Sales and Market Share by Type (2011-2016)

Table Europe Letairis Sales Share by Type (2011-2016)

Figure Sales Market Share of Letairis by Type (2011-2016)

Figure Europe Letairis Sales Growth Rate by Type (2011-2016)

Table Europe Letairis Revenue and Market Share by Type (2011-2016)

Table Europe Letairis Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Letairis by Type (2011-2016)

Figure Europe Letairis Revenue Growth Rate by Type (2011-2016)

Table Europe Letairis Sales and Market Share by Countries (2011-2016)

Table Europe Letairis Sales Share by Countries (2011-2016)

Figure Sales Market Share of Letairis by Countries (2011-2016)

Table Europe Letairis Revenue and Market Share by Countries (2011-2016)

Table Europe Letairis Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Letairis by Countries (2011-2016)

Table Europe Letairis Sales and Market Share by Application (2011-2016)

Table Europe Letairis Sales Share by Application (2011-2016)

Figure Sales Market Share of Letairis by Application (2011-2016)

Figure Germany Letairis Sales and Growth Rate (2011-2016)

Figure Germany Letairis Revenue and Growth Rate (2011-2016)

Figure Germany Letairis Sales Price Trend (2011-2016)

Table Germany Letairis Sales by Manufacturers (2015 and 2016)

Table Germany Letairis Market Share by Manufacturers (2015 and 2016)

Table Germany Letairis Sales by Type (2015 and 2016)

Table Germany Letairis Market Share by Type (2015 and 2016)

Table Germany Letairis Sales by Application (2015 and 2016)

Table Germany Letairis Market Share by Application (2015 and 2016)

Figure France Letairis Sales and Growth Rate (2011-2016)

Figure France Letairis Revenue and Growth Rate (2011-2016)

Figure France Letairis Sales Price Trend (2011-2016)

Table France Letairis Sales by Manufacturers (2015 and 2016)

Table France Letairis Market Share by Manufacturers (2015 and 2016)

Table France Letairis Sales by Type (2015 and 2016)

Table France Letairis Market Share by Type (2015 and 2016)

Table France Letairis Sales by Application (2015 and 2016)

Table France Letairis Market Share by Application (2015 and 2016)

Figure UK Letairis Sales and Growth Rate (2011-2016)

Figure UK Letairis Revenue and Growth Rate (2011-2016)

Figure UK Letairis Sales Price Trend (2011-2016)

Table UK Letairis Sales by Manufacturers (2015 and 2016)

Table UK Letairis Market Share by Manufacturers (2015 and 2016)

Table UK Letairis Sales by Type (2015 and 2016)

Table UK Letairis Market Share by Type (2015 and 2016)

Table UK Letairis Sales by Application (2015 and 2016)

Table UK Letairis Market Share by Application (2015 and 2016)

Figure Russia Letairis Sales and Growth Rate (2011-2016)

Figure Russia Letairis Revenue and Growth Rate (2011-2016)

Figure Russia Letairis Sales Price Trend (2011-2016)

Table Russia Letairis Sales by Manufacturers (2015 and 2016)

Table Russia Letairis Market Share by Manufacturers (2015 and 2016)

Table Russia Letairis Sales by Type (2015 and 2016)

Table Russia Letairis Market Share by Type (2015 and 2016)

Table Russia Letairis Sales by Application (2015 and 2016)

Table Russia Letairis Market Share by Application (2015 and 2016)

Figure Italy Letairis Sales and Growth Rate (2011-2016)

Figure Italy Letairis Revenue and Growth Rate (2011-2016)

Figure Italy Letairis Sales Price Trend (2011-2016)

Table Italy Letairis Sales by Manufacturers (2015 and 2016)

Table Italy Letairis Market Share by Manufacturers (2015 and 2016)

Table Italy Letairis Sales by Type (2015 and 2016)

Table Italy Letairis Market Share by Type (2015 and 2016)

Table Italy Letairis Sales by Application (2015 and 2016)

Table Italy Letairis Market Share by Application (2015 and 2016)

Figure Spain Letairis Sales and Growth Rate (2011-2016)

Figure Spain Letairis Revenue and Growth Rate (2011-2016)

Figure Spain Letairis Sales Price Trend (2011-2016)

Table Spain Letairis Sales by Manufacturers (2015 and 2016)

Table Spain Letairis Market Share by Manufacturers (2015 and 2016)

Table Spain Letairis Sales by Type (2015 and 2016)

Table Spain Letairis Market Share by Type (2015 and 2016)

Table Spain Letairis Sales by Application (2015 and 2016)

Table Spain Letairis Market Share by Application (2015 and 2016)

Figure Benelux Letairis Sales and Growth Rate (2011-2016)

Figure Benelux Letairis Revenue and Growth Rate (2011-2016)

Figure Benelux Letairis Sales Price Trend (2011-2016)

Table Benelux Letairis Sales by Manufacturers (2015 and 2016)

Table Benelux Letairis Market Share by Manufacturers (2015 and 2016)

Table Benelux Letairis Sales by Type (2015 and 2016)

Table Benelux Letairis Market Share by Type (2015 and 2016)

Table Benelux Letairis Sales by Application (2015 and 2016)

Table Benelux Letairis Market Share by Application (2015 and 2016)

Table Letairis Basic Information List

Table Pfizer, Inc. (US) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Letairis Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information List

Table GlaxoSmithKline Plc (UK) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc (UK) Letairis Sales Market Share (2011-2016)

Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List

Table Bayer HealthCare Pharmaceuticals (Germany) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Pharmaceuticals (Germany) Letairis Sales Market Share (2011-2016)

Table Sanofi S.A (France) Basic Information List

Table Sanofi S.A (France) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A (France) Letairis Sales Market Share (2011-2016)

Table Daiichi Sankyo Co., Ltd. (Japan) Basic Information List

Table Daiichi Sankyo Co., Ltd. (Japan) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo Co., Ltd. (Japan) Letairis Sales Market Share (2011-2016)

Table Eli Lilly and Company (US) Basic Information List

Table Eli Lilly and Company (US) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly and Company (US) Letairis Sales Market Share (2011-2016)

Table The Novartis Group (Switzerland) Basic Information List

Table The Novartis Group (Switzerland) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table The Novartis Group (Switzerland) Letairis Sales Market Share (2011-2016)

Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List

Table Actelion Pharmaceuticals Ltd. (Switzerland) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Actelion Pharmaceuticals Ltd. (Switzerland) Letairis Sales Market Share (2011-2016)

Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List

Table Nippon Shinyaku Co., Ltd. (Japan) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nippon Shinyaku Co., Ltd. (Japan) Letairis Sales Market Share (2011-2016)

Table Cipla Limited (India) Basic Information List

Table Cipla Limited (India) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cipla Limited (India) Letairis Sales Market Share (2011-2016)

Table Arena Pharmaceuticals, Inc. (US) Basic Information List

Table Arena Pharmaceuticals, Inc. (US) Letairis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arena Pharmaceuticals, Inc. (US) Letairis Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Letairis

Figure Manufacturing Process Analysis of Letairis

Figure Letairis Industrial Chain Analysis

Table Raw Materials Sources of Letairis Major Manufacturers in 2015

Table Major Buyers of Letairis

Table Distributors/Traders List

Figure Germany Letairis Sales and Growth Rate Forecast (2016-2021)

Figure Germany Letairis Revenue and Growth Rate Forecast (2016-2021)

Figure France Letairis Sales and Growth Rate Forecast (2016-2021)

Figure France Letairis Revenue and Growth Rate Forecast (2016-2021)

Figure UK Letairis Sales and Growth Rate Forecast (2016-2021)

Figure UK Letairis Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Letairis Sales and Growth Rate Forecast (2016-2021)

Figure Russia Letairis Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Letairis Sales and Growth Rate Forecast (2016-2021)

Figure Italy Letairis Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Letairis Sales and Growth Rate Forecast (2016-2021)

Figure Spain Letairis Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Letairis Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Letairis Revenue and Growth Rate Forecast (2016-2021)

Table Europe Letairis Sales Forecast by Type (2016-2021)

Table Europe Letairis Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370